chevron_leftBack
As of 24 April 2025, Novacyt S.A. has a market cap of $37.89M USD, ranking #26352 globally and #371 in France. It ranks #2665 in the Healthcare sector, and #324 in the Medical Devices industry.
Key Stats
Market Cap
$37.89MUSD
33.29M EUR
Enterprise Value
$11.31MUSD
9.94M EUR
Revenue (TTM)
$24.91MUSD
21.89M EUR
EBITDA (TTM)
-$51.34MUSD
-45.11M EUR
Net Income (TTM)
-$50.52MUSD
-44.4M EUR
EBITDA Margin
-206%
Profit Margin
-203%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Lyn Rees
open_in_new
Employees
237
Founded
2006
Website
novacyt.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.3% | -5.6% | -14% | -23% | -32% | -39% |
Upcoming Earnings
Earnings Date
Wed, Apr 30
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ALNOV
Novacyt SA
ISIN: FR0010397232
Shares Out.:
Shares Outstanding:
70.626M1
Shares Float:
70.479M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.4704 EUR | |
|
NCYT
Novacyt SA
ISIN: FR0010397232
|
40 GBX | |
|
NVYTF
Novacyt SA
ISIN: FR0010397232
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.5380 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Novacyt S.A.
Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, France, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, and Yourgene Health segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The company was incorporated in 2006 and is based in Le Vésinet, France.
